Live Breaking News & Updates on Clarus Therapeutics Inc

Stay updated with breaking news from Clarus therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lipocine Inc. (LPCN) stock surged in the after-hours on Wednesday after a recent announcement


Settlement With Clarus Therapeutics
On July 14, 2021, Lipocine Inc entered into a global settlement and license agreement with Clarus Therapeutics Inc (Clarus) to resolve all outstanding claims in the ongoing intellectual property battle between the two companies as well as the ongoing interference proceeding between the two companies.
Both companies agreed to dismiss the Lipocine Inc. v Clarus Therapeutics, Inc., No 19-cv-622 (WCB) litigation presently pending in the U.S. District Court for the District of Delaware and interference proceedings captioned Clarus Therapeutics, Inc. v. Lipocine Inc., Interference No. 106,128 presently pending in the U.S. Patent and Trademark. The terms of the settlement remain confidential. ....

United States , Raymond James Human Health Innovation Conference , Clarus Therapeutics Inc , Drug Administration , Lipocine Inc , Us District Court , International Liver Congress , Clarus Therapeutics , Ladenburg Thalmann Healthcare Conference , European Association , Digital Event , Lytham Partners Summer , Investigational New Drug Application , Patent Infringement Case , Clarus Therapeutic , Judge Bryson , ஒன்றுபட்டது மாநிலங்களில் , ரேமஂட் ஜேம்ஸ் மனிதன் ஆரோக்கியம் கண்டுபிடிப்பு மாநாடு , கிளாரஸ் சிகிச்சை இன்க் , எங்களுக்கு மாவட்டம் நீதிமன்றம் , சர்வதேச கல்லீரல் காங்கிரஸ் , கிளாரஸ் சிகிச்சை , ஐரோப்பிய சங்கம் , டிஜிட்டல் நிகழ்வு , நீதிபதி பிரைசன் ,